Thymosin Alpha-1 is a 28-amino acid peptide derived from thymosin fraction 5, investigated for T-cell differentiation, innate immune activation, cytokine regulation, and antiviral response research.
| Molecular Weight | 3108.5 g/mol |
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
Thymosin Alpha-1 (Tα1) is a synthetic version of a naturally occurring peptide produced by the thymus gland. It is a potent immune modulator that plays a critical role in controlling the body's adaptive and innate immune responses.
Tα1 works by stimulating the production and differentiation of T-lymphocytes (specifically CD4+ and CD8+ cells) and enhancing the activity of Natural Killer (NK) cells. It also modulates the production of cytokines, helping the immune system to mount a strong defense against pathogens while preventing the over-inflammation (cytokine storm) seen in severe infections.
Research indicates that Thymosin Alpha-1 is highly effective in the study of chronic viral infections like Hepatitis B and C, as well as its potential as an adjuvant in cancer therapy. It is also a major subject for research into long-term immunity, vaccine effectiveness, and the treatment of autoimmune disorders.